Log in to save to my catalogue

Epstein–Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients

Epstein–Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_66f893d4aea54bc5a35a2c51e7fe228b

Epstein–Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients

About this item

Full title

Epstein–Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients

Publisher

Basel: MDPI AG

Journal title

Viruses, 2022-08, Vol.14 (9), p.1872

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Beyond their pulmonary disease, many COVID-19 patients experience a complex constellation of characteristics, including hyperinflammatory responses, autoimmune disorders, and coagulopathies. However, the pathogenesis of these aspects of COVID-19 is obscure. More than 90% of people are latently infected with the lymphotropic herpesviruses Epstein–Ba...

Alternative Titles

Full title

Epstein–Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_66f893d4aea54bc5a35a2c51e7fe228b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_66f893d4aea54bc5a35a2c51e7fe228b

Other Identifiers

ISSN

1999-4915

E-ISSN

1999-4915

DOI

10.3390/v14091872

How to access this item